MLR Maelor

RNS Number:8467R
Maelor PLC
28 September 2005

28 September 2005



                       Appointment of new Chief Executive



Maelor plc, the specialist healthcare products company, announces the
appointment of Tim Wright as Chief Executive, in succession to Stephen Appelbee
who after three and half years with the Company has left to pursue other
business interests.



Tim Wright (39) was previously General Manager, Ireland and Vice President,
International Marketing at Elan Pharmaceuticals. His earlier experience was
gained in senior management positions in the product development and marketing
divisions of both Smithkline Beecham and Pfizer.



Alastair Macpherson, Chairman, said 'Tim is an experienced and successful
manager, whose proven expertise in international marketing in the pharmaceutical
industry will be of great benefit to Maelor during the next phase in the
Company's development.'



Tim Wright will take up his appointment with effect from 17th October 2005.



In the last five years, Mr Wright has been a Director of Port la Salle
Management Limited. He had no further directorships as defined in schedule 2 (g)
of the AIM Rules.



                                     -ends-





Enquiries:
Alastair Macpherson, Chairman, Maelor plc                Tel: 07831 423059


Ben Atwell, Financial Dynamics                           Tel: 0207 831 3113





Notes to Editors:

Maelor plc is an AIM-listed specialist healthcare products company, which
operates on a virtual basis, outsourcing both product development and
manufacturing. The company has several products on the market including OptiFlo,
ContiSol and Volplex.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

BOAPKOKKFBKDDCB

Maelor (LSE:MLR)
Historical Stock Chart
From Dec 2024 to Jan 2025

Maelor (LSE:MLR)
Historical Stock Chart
From Jan 2024 to Jan 2025